Diabetes Research and Clinical Practice
Volume 91, Issue 1 , Pages 1-12 , January 2011

Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials

  • Michael K. Baker

      Affiliations

    • Boden Institute of Obesity, Nutrition and Exercise, Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9351 9858; fax: +61 2 9351 9204.
    • ,
  • Kylie Simpson

      Affiliations

    • Exercise Health and Performance, The University of Sydney, Lidcombe, Australia
    • ,
  • Bradley Lloyd

      Affiliations

    • Exercise Health and Performance, The University of Sydney, Lidcombe, Australia
    • ,
  • Adrian E. Bauman

      Affiliations

    • School of Public Health, The University of Sydney, Camperdown, Australia
    • ,
  • Maria A. Fiatarone Singh

      Affiliations

    • Boden Institute of Obesity, Nutrition and Exercise, Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia
    • Hebrew Senior Life and Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA USA

Received 24 May 2010 ,Revised 22 June 2010 ,Accepted 28 June 2010.

References 

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
  2. Australian Institute of Health and Welfare . Diabetes: Australian facts. In: Diabetes series no. 8. Cat. no. CVD 40. Canberra: AIHW; 2008;
  3. Economic costs of diabetes in the U.S. 2007. Diabetes Care 2008;31(3): 596–15.
  4. Laaksonen DE, Lindstrom J, Lakka TA, Eriksson JG, Niskanen L, Wikstrom K, et al. Physical activity in the prevention of type 2 diabetes: the finnish diabetes prevention study. Diabetes. 2005;54(1):158–165
  5. Lindstrom J, Peltonen M, Tuomilehto J, Lindstrom J, Peltonen M, Tuomilehto J. Lifestyle strategies for weight control: experience from the finnish diabetes prevention study. Proc Nutr Soc. 2005;64(1):81–88
  6. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ (Clin Res Ed). 2007;334(7588):299
  7. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque IFM, Richter B, Mauricio D. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev (Online). 2008;(3):CD003054
  8. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus. J Clin Epidemiol. 1998;51(12):1235–1241
  9. Dunstan DW, Daly RM, Owen N, Jolley D, Vulikh E, Shaw J, et al. Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes. Diabetes Care. 2005;28(1):3–9
  10. Dunstan DW, Vulikh E, Owen N, Jolley D, Shaw J, Zimmet P. Community center-based resistance training for the maintenance of glycemic control in adults with type 2 diabetes. Diabetes Care. 2006;29(12):2586–2591
  11. Ubc clinical significance calculator, http://www.healthcare.ubc.ca/calc/clinsig.html; 2002.
  12. Middel B, van Sonderen E. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care. 2002;2:pe15
  13. Rhea MR. Determining the magnitude of treatment effects in strength training research through the use of the effect size. J Strength Cond Res. 2004;18(4):918–920
  14. Coe R. Effect size calculator, 2000. Available from: www.cemcentre.org [cited 09.06].
  15. How to use the evidence: assessment and application of scientific evidence. In: Handbook series on preparing clinical practice guidelines. National Health and Medical Research Council; 2000.
  16. Diabetes Prevention Program Research Group . The diabetes prevention program (dpp): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171
  17. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The finnish diabetes prevention study (dps): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–3236
  18. Lindahl B, Nilsson TK, Borch-Johnsen K, Roder ME, Soderberg S, Widman L, et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems. Scand J Public Health. 2009;37(4):434–442
  19. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing niddm in people with impaired glucose tolerance. The da qing igt and diabetes study. Diabetes Care. 1997;20(4):537–544
  20. Pan XR, Hu YH, Li GW, Liu PA, Bennett PH, Howard BV. Impaired glucose tolerance and its relationship to ecg-indicated coronary heart disease and risk factors among Chinese. Da qing igt and diabetes study. Diabetes Care. 1993;16(1):150–156
  21. Bo S, Ciccone G, Baldi C, Benini L, Dusio F, Forastiere G, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med. 2007;22(12):1695–1703
  22. Uutela A, Absetz P, Nissinen A, Valve R, Talja M, Fogelholm M. Health psychological theory in promoting population health in paijat-hame, finland: First steps toward a type 2 diabetes prevention study. J Health Psychol. 2004;9(1):73–84
  23. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in igt males. Diabetes Res Clin Pract. 2005;67(2):152–162
  24. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (idpp-1). Diabetologia. 2006;49(2):289–297
  25. Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type ii diabetes in subjects with impaired glucose tolerance: the diabetes prevention study (dps) in finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia. 1999;42(7):793–801
  26. Diabetes Reasearch Program Research Group . The diabetes prevention program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22(4):623–634
  27. Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med. 1999;246(1):105–112
  28. Welsh S, Davis C, Shaw A. Development of the food guide pyramid. Nutr Today. 1992;12–23
  29. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [see comment]. N Engl J Med. 2002;346(6):393–403
  30. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350
  31. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the stop-niddm randomised trial. Lancet. 2002;359(9323):2072–2077
  32. de Morton NA. The pedro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Aust J Physiother. 2009;55(2):129–133
  33. Bandura A. Social Cognitive Theory of mass communications. In: 2nd ed..  Bryant J,  Zillman D editor. Media effects: advances in theory and research. Hillsdale, NJ: Erlbaum; 2002;
  34. Marcus BH, Selby VC, Niaura RS, Rossi JS. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport. 1992;63(1):60–66
  35. Blue CL. Does the Theory of Planned Behavior identify diabetes-related cognitions for intention to be physically active and eat a healthy diet?. Public Health Nurs. 2007;24(2):141–150
  36. Weyrich P, Stefan N, Haring HU, Laakso M, Fritsche A. Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. J Mol Med. 2007;85(2):107–117
  37. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science. 2007;316(5829):1341–1345
  38. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881–885
  39. Wen J, Rönn T, Olsson A, Yang Z, Lu B, Du Y, et al. Investigation of type 2 diabetes risk alleles support cdkn2a/b, cdkal1, and tcf7l2 as susceptibility genes in a Han Chinese Cohort. PLoS ONE. 2010;5(2):e9153
  40. Adeyemo A, Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics. 2010;13(2):72–79
  41. Miller WC, Koceja DM, Hamilton EJ. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord. 1997;21(10):941–947
  42. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the finnish diabetes prevention study. Lancet. 2006;368(9548):1673–1679
  43. Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004;12(9):1426–1434
  44. Lindstrom J, Peltonen M, Eriksson JG, Louheranta A, Fogelholm M, Uusitupa M, et al. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the finnish diabetes prevention study. Diabetologia. 2006;49(5):912–920
  45. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–2107
  46. Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, et al. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care. 2006;29(6):1237–1241
  47. Aldana SG, Barlow M, Smith R, Yanowitz FG, Adams T, Loveday L, et al. The diabetes prevention program: a worksite experience. AAOHN J. 2005;53(11):499–505quiz 506-7
  48. Boltri JM, Davis-Smith YM, Seale JP, Shellenberger S, Okosun IS, Cornelius ME. Diabetes prevention in a faith-based setting: results of translational research. J Public Health Manag Pract. 2008;14(1):29–32
  49. Cramer JS, Sibley RF, Bartlett DP, Kahn LS, Loffredo L. An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes. Diabetes Educ. 2007;33(3):503–508
  50. Davis-Smith YM, Boltri JM, Seale JP, Shellenberger S, Blalock T, Tobin B. Implementing a diabetes prevention program in a rural African-American church. J Natl Med Assoc. 2007;99(4):440–446
  51. Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, et al. Clinical and cost-effectiveness of primary prevention of type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the kora survey 2000. Diabet Med. 2007;24(5):473–480
  52. Smith-Ray RL, Almeida FA, Bajaj J, Foland S, Gilson M, Heikkinen S, et al. Translating efficacious behavioral principles for diabetes prevention into practice. Health Promot Pract. 2007;
  53. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the diabetes prevention program into the community. The deploy pilot study. Am J Prevent Med. 2008;35(4):357–363
  54. Ackermann RT, Marrero DG. Adapting the diabetes prevention program lifestyle intervention for delivery in the community: the ymca model. Diabetes Educ. 2007;33(1):69;74-5, 77-8
  55. Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, et al. National type 2 diabetes prevention programme in finland: Fin-d2d. Int J Circumpolar Health. 2007;66(2):101–112
  56. Simmons RK, Unwin N, Griffin SJ. International diabetes federation: an update of the evidence concerning the prevention of type 2 diabetes. Diabetes Res Clin Pract. 2010;87(2):143–149

PII: S0168-8227(10)00332-3

doi: 10.1016/j.diabres.2010.06.030

Diabetes Research and Clinical Practice
Volume 91, Issue 1 , Pages 1-12 , January 2011

Article Tools

* Image Usage & Resolution